AF Cryoablation is an effective day case treatment: The United Kingdom PolarX versus AFA experience.
Shohreh HonarbakhshJonathan D RaybuckJoão MesquitaRahul HerlekarRichard TillNeil T SrinivasanEdward DuncanFong T LeongRajdip DulaiRick VeaseySandeep PanikkerJohn PaiseyBalasubramanian RamgopalMoloy DasWissam AhmedJonathan SahuMark J EarleyMalcolm C FinlayRichard J SchillingRoss J HunterPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
This large-scale UK multicentre study has shown that Cryoballoon PVI is a safe effective day case procedure. PVI using the PolarX Cryoballoon was similarly safe, and effective as the AFA Cryoballoon. The cryoablation metrics achieved with the PolarX Cryoballoon were different to that reported with the AFA Cryoballoon. Modified cryoablation targets are required when utilizing the PolarX Cryoballoon.